Anu Mahashabde

Title: Anu Mahashabde: Innovator in Serotonin Reuptake Inhibitor Delivery

Introduction

Anu Mahashabde is a notable inventor based in Kendall Park, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the delivery of serotonin reuptake inhibitors (SSRIs). His innovative approach aims to enhance the treatment of various mental health conditions.

Latest Patents

Anu Mahashabde holds a patent for a method of systematically delivering SSRIs. This patent outlines methods and compositions for the intravaginal or rectal delivery of selected SSRIs to the systemic circulation. The invention is particularly useful in treating depression, migraine headaches, chronic pain, psychoactive substance abuse disorders, pre-menstrual dysphoric disorder (PMDD), and obsessive-compulsive disorders. The compositions can be formulated for immediate release or controlled release of SSRIs over an extended period, with fluoxetine being a preferred SSRI.

Career Highlights

Anu Mahashabde is currently associated with Duramed Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in drug delivery systems has positioned him as a valuable asset in the field.

Collaborations

Anu collaborates with talented professionals, including Martha Francine Kay and Brian Glazer, who contribute to the advancement of his projects and ideas.

Conclusion

Anu Mahashabde's work in the delivery of SSRIs represents a significant advancement in the treatment of mental health disorders. His innovative methods and compositions have the potential to improve patient outcomes and enhance the effectiveness of SSRIs.